SCHEMBL2965972

SCHEMBL2965972

CC1=C(c2c(C)cc(C)cc2C)c2ccc(Br)cc2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.39
TDP2 O95551 1/20 0.38
PGR P06401 2/20 0.37
RAPGEF4 Q8WZA2 2/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
GSK3B P49841 1/20 0.32
PNMT P11086 3/20 0.32
ADRA2A P08913 2/20 0.32
ADRA2B P18089 2/20 0.32
ADRA2C P18825 2/20 0.32
PARP10 Q53GL7 1/20 0.32
PARP11 Q9NR21 1/20 0.32
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2963682 0.90 CHEK2 (0.36) METAP1TDP2PGRRAPGEF4PNMT
SCHEMBL2959837 0.79 ESR1 (0.48) METAP1TDP2PGRCA1CA2
SCHEMBL2959335 0.75 ESR1 (0.42) METAP1TDP2PGRCA1CA2
SCHEMBL2974856 0.75 PGR (0.37) METAP1TDP2PGRCA1CA2
SCHEMBL2971561 0.73 METAP1 (0.47) METAP1TDP2PGRCA1CA2
SCHEMBL16913075 0.73 ESR1 (0.47) METAP1TDP2PGRCA1CA2
SCHEMBL16442398 0.73 METAP1 (0.43) METAP1TDP2PGRCA1CA2
SCHEMBL2976308 0.71 MEN1 (0.47) METAP1TDP2PGRRAPGEF4PARP10
SCHEMBL2967198 0.71 RAPGEF4 (0.32) RAPGEF4MEN1ALDH1A1MAPTKMT2A
SCHEMBL2966003 0.70 PIM1 (0.33) RAPGEF4PARP10PARP11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 METAP1 1352/4885TDP2 4139/4885PGR 3088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.